Oriola Oyj (HEL: OKDBV)

Market Cap	162.76M
Revenue (ttm)	1.63B
Net Income (ttm)	-5.10M
Shares Out	181.41M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	11.82
Dividend	0.07 (7.73%)
Ex-Dividend Date	n/a

Volume	212,913
Open	0.903
Previous Close	0.907
Day's Range	0.890 - 0.905
52-Week Range	0.850 - 1.174
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 4, 2025

About Oriola Oyj

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed medicines; and provision of advisory services. The company serves pharmaceutical companies, pharmacies, veterinarians, and hospitals. Oriola Oyj was i...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2006
• Employees: 895
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: OKDBV

Financial Performance

In 2023, Oriola Oyj's revenue was 1.50 billion, a decrease of -2.90% compared to the previous year's 1.54 billion. Losses were -20.70 million, 762.5% more than in 2022.